OR WAIT null SECS
Company delivers additional supply chain logistics and distribution experience to specialty pharmaceutical market.
Terebellum, a healthcare and business consulting services provider, will be adopting the name of its global parent, AscellaHealth. It joins US-based pharma distribution and patient-management organization, Optime Care, in doing so. The goal, says Terebellum, is to reflect the scale of its operations, but the company will continue to maintain its priorities as it pertains to current business operations and client relationships.
The business specializes in providing end-to-end solutions to pharma manufacturers and other industry stakeholders to help streamline product commercialization, improve medication access, reduce costs, and enhance patient outcomes for specialty and rare disease patients.
With locations in Dublin, Ireland and Manchester, UK, former Terebellum provides pre-commercialization and market access support, supply chain logistics, distribution and fulfilment and pharma financial services to UK and European pharma manufacturers and healthcare organizations.
“It’s our strong belief that to optimize outcomes in specialty healthcare a specialized approach is needed, due to the specific challenges associated with rare conditions,” comments Craig Caceci, managing director at AscellaHealth EU/UK. “The AscellaHealth name provides an opportunity to highlight how we are perfectly positioned to offer uniquely tailored solutions across the globe to ensure streamlined medication access and the best possible treatment journey for rare and orphan disease patients.”